GlaxoSmithKline will become the latest company to publish all its payments to doctors, and those payments will be capped at $150,000 a year, CEO Andrew Witty said. GSK previously opposed doctor ...

GlaxoSmithKline CEO Andrew Witty says the company's drug candidates position the company for future success. Read more about why Witty is so optimistic.

Last week GlaxoSmithKline announced that its CEO, Sir Andrew Witty, would be stepping down from his post in early 2017. As outlined by the Financial Times, his tenure at GSK has been turbulent ...

Glaxo SmithKline recently announced that its CEO, Andrew Witty, will be out the door as of March 31, 2017 – a development many were expecting. GSK has made headlines during Witty’s tenure, but ...

GlaxoSmithKline said Andrew Witty would retire as chief executive in March 2017 after roughly 10 years as CEO of the drug maker.

Two views exist of Sir Andrew Witty. He could be seen as the visionary leader who restructured GlaxoSmithKline for long-term survival in a changing healthcare industry, or a failed chief executive ...

GlaxoSmithKline (NYSE: GSK) Q3 2016 Earnings Conference Call October 26, 2016 9:00 AM ET Executives Sir Andrew Witty - Chief Executive Officer Simon Dingemans - Chief Financial Officer Analysts ...

GlaxoSmithKline’s Andrew Witty: On a Mission Andrew Witty recently met with Institutional Investor Staff Writer Neil Sen to discuss how his early desire to “do something connected to improving ...

GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Andrew Witty Witty has told GSK's board that he ...

Andrew Witty is seeking to calm anxious employees and keep the company growing while facing public outrage over health-insurer practices.

GlaxoSmithKline CEO on why drugs cost so much Sir Andrew Witty says that there's frankly not enough transparency when it comes to drug prices in the U.S.

Andrew Witty is coming out of a brief retirement to become CEO of Optum, which is part of UnitedHealth.